# CRP, Procalcitonin and Pro-BNP as Diagnostic and Prognostic Markers in AECOPD

> **NCT06514599** · — · COMPLETED · sponsor: **Kanuni Sultan Suleyman Training and Research Hospital** · enrollment: 196 (actual)

## Conditions studied

- COPD Exacerbation Acute

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06514599
- **Lead sponsor:** Kanuni Sultan Suleyman Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-15
- **Primary completion:** 2024-02-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06514599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06514599, "CRP, Procalcitonin and Pro-BNP as Diagnostic and Prognostic Markers in AECOPD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06514599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*